1. "Sean Devlin"
  2. "Graduate Medical Education"
Formats
  1. Meeting Abstract (27)
  2. Journal Article (20)
Groups
  1. Biostatistics Service (47)
  2. Center for Hematologic Malignancies (47)
  3. Department of Medicine (47)
  4. Epidemiology and Biostatistics (47)
  5. Graduate Medical Education (47)
  6. Hematologic Malignancies, Division of (47)

More Groups

People
  1. Sean Devlin (47)
  2. Miguel-Angel Perales (32)
  3. Sergio Giralt (31)
  4. Michael Scordo (26)
  5. Gunjan Shah (25)
  6. Parastoo Dahi (21)

More People

Years
  1. 2024 (2)
  2. 2023 (22)
  3. 2022 (13)
  4. 2021 (4)
  5. 2020 (2)
  6. 2017 (1)

More Years

Publications
  1. Blood (17)
  2. Transplantation and Cellular Therapy (6)
  3. Clinical Lymphoma, Myeloma and Leukemia (4)
  4. Journal of Clinical Oncology (3)
  5. American Journal of Hematology (2)
  6. Blood Advances (2)

More Publications

Publishers
  1. American Society of Hematology (19)
  2. Elsevier Inc. (12)
  3. American Society of Clinical Oncology (3)
  4. Nature Publishing Group (3)
  5. American Association for the Advancement of Science (2)
  6. Biomed Central Ltd (1)

More Publishers

Results (47)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • High-risk and silent clonal hematopoietic genotypes in patients with nonhematologic cancer
    Journal Article

    Stonestrom, A. J.; Menghrajani, K. N.; Devlin, S. M.; Franch-Expósito, S.; Ptashkin, R. N.; Patel, S. Y.; Spitzer, B.; Wu, X.; Jee, J.; Vela, P. S.; more...
    Blood Advances (2024)

    Fulltext@MSK | Save
  • Reduced-intensity compared to nonmyeloablative conditioning in patients with non-Hodgkin lymphoma undergoing allogeneic hematopoietic stem cell transplantation
    Journal Article

    Nath, K.; Peterson, K.; Brown, S.; Devlin, S.; Rodriguez, N.; Barker, J.; Giralt, S.; Gyurkocza, B.; Jakubowski, A.; Papadopoulos, E.; more...
    Transplantation and Cellular Therapy (2024)

    Fulltext@MSK | Save
  • Comparison of bendamustine versus fludarabine/cyclophosphamide lymphodepletion in adult patients receiving CD19 CAR-T cell therapy
    Meeting Abstract

    Landego, I.; Nemirovsky, D.; Devlin, S. M.; Wills, B.; Parascondola, A.; Saldia, A.; Dahi, P. B.; Tomas, A. A.; Ip, A.; Suh, H. C.; more...
    Blood (2023)

    Fulltext@MSK | Save
  • Analysis of 3,843 unrelated donors (URD) for 455 allograft candidates reveals low URD availability with marked racial/ ethnic disparities: Major implications for transplant center & registry operations
    Meeting Abstract

    Fingrut, W. B.; Davis, E.; Archer, A.; Brown, S.; Devlin, S. M.; Nhaissi, M.; Rapoport, C.; Chinapen, S.; Kelly, A.; Wells, D.; more...
    Blood (2023)

    Fulltext@MSK | Save
  • Impact of response to systemic bridging therapy on clinical outcomes and cytokine profiles in patients receiving CD19-CAR T-cell therapy for B-cell lymphoma
    Meeting Abstract

    Wills, B.; Shouval, R.; Flynn, J. R.; Devlin, S. M.; Parascondola, A.; Saldia, A.; Imber, B. S.; Tomas, A. A.; Landego, I.; Lin, R. J.; more...
    Blood (2023)

    Fulltext@MSK | Save
  • CNS radiotherapy as bridging prior to CAR T-cell therapy for non-Hodgkin B-cell lymphoma
    Meeting Abstract

    Cederquist, G.; Schefflein, J.; Devlin, S. M.; Hubbeling, H.; Tringale, K.; Shah, G. L.; Tomas, A. A.; Shouval, R.; Hajj, C.; Fregonese, B.; more...
    Blood (2023)

    Fulltext@MSK | Save
  • Gender disparities in allograft access due to HLA-sensitization in multiparous women: Implications for evaluation of female patients for alternative donor transplantation
    Meeting Abstract

    Fingrut, W. B.; Davis, E.; Archer, A.; Brown, S.; Devlin, S. M.; Chinapen, S.; Scaradavou, A.; Politikos, I.; Blouin, A.; Shaffer, B. C.; more...
    Blood (2023)

    Fulltext@MSK | Save
  • Stem cell utilization in the era of novel therapies for multiple myeloma
    Meeting Abstract

    Nishimura, N.; Nemirovsky, D.; Devlin, S. M.; Dahi, P. B.; Landau, H.; Lahoud, O. B.; Scordo, M.; Shah, G. L.; Mailankody, S.; Hassoun, H.; more...
    Blood (2023)

    Fulltext@MSK | Save
  • A phase II trial of prophylactic anakinra to prevent neurotoxicity in patients receiving anti-CD19 CAR T-cell therapy for relapsed or refractory lymphoma: Final results from cohort 2
    Meeting Abstract

    Nath, K.; Devlin, S. M.; Sauter, C. S.; Palomba, M. L.; Shah, G. L.; Dahi, P. B.; Lin, R. J.; Scordo, M.; Perales, M. A.; Leslie, L. A.; more...
    Blood (2023)

    Fulltext@MSK | Save
  • Dynamics of radiomic features following bridging therapy determine CD19 chimeric antigen receptor (CAR) T-cell therapy outcome
    Meeting Abstract

    Hubbeling, H.; Leithner, D.; Silverman, E. A.; Flynn, J. R.; Devlin, S. M.; Shah, G. L.; Fregonese, B.; Bedmutha, A.; Wills, B.; Tomas, A. A.; more...
    Blood (2023)

    Fulltext@MSK | Save